Loading...

Identification of “Multiple Components-Multiple Targets-Multiple Pathways” Associated with Naoxintong Capsule in the Treatment of Heart Diseases Using UPLC/Q-TOF-MS and Network Pharmacology

Naoxintong capsule (NXT) is a commercial medicinal product approved by the China Food and Drug Administration which is used in the treatment of stroke and coronary heart disease. However, the research on the composition and mechanism of NXT is still lacking. Our research aimed to identify the absorb...

Full description

Saved in:
Bibliographic Details
Main Authors: Xianghui Ma, Bin Lv, Pan Li, Xiaoqing Jiang, Qian Zhou, Xiaoying Wang, Xiumei Gao
Format: Artigo
Language:Inglês
Published: Hindawi Limited 2016-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2016/9468087
Tags: Add Tag
No Tags, Be the first to tag this record!